Mycophenolate Mofetil
Rank #404 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$22.0M
Total Cost
152,937
Total Claims
$22.0M
Total Cost
5,248
Prescribers
$144
Cost per Claim
18,710
Beneficiaries
259,728
30-Day Fills
$4,192
Avg Cost/Provider
29
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$22.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $22.0M total
Top Prescribers of Mycophenolate Mofetil
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Rajiv Shah | Ophthalmology | Winston Salem, NC | 652 | $116K |
| 2 | Paul Dellaripa | Rheumatology | Boston, MA | 100 | $53K |
| 3 | Emily Pineda | Rheumatology | San Antonio, TX | 16 | $52K |
| 4 | Alberto Santos-Ocampo | Rheumatology | Honolulu, HI | 70 | $49K |
| 5 | Steffan Schulz | Rheumatology | Philadelphia, PA | 118 | $46K |
| 6 | David Maxwell | Rheumatology | Hampton, VA | 82 | $42K |
| 7 | Matthew Lammi | Pulmonary Disease | Baltimore, MD | 95 | $42K |
| 8 | Cynthia Gibson | Nurse Practitioner | Rochester, NY | 204 | $42K |
| 9 | Debra Guntrum | Nurse Practitioner | Rochester, NY | 227 | $41K |
| 10 | Gerald Ho | Rheumatology | La Palma, CA | 290 | $40K |
| 11 | Fabian Mendoza Ballesteros | Rheumatology | Philadelphia, PA | 163 | $39K |
| 12 | Michael Markowski | Neurology | Hyannis, MA | 11 | $38K |
| 13 | Jenny Murase | Dermatology | Mountain View, CA | 11 | $38K |
| 14 | Chad Witt | Pulmonary Disease | Saint Louis, MO | 129 | $38K |
| 15 | Traci Adams | Pulmonary Disease | Dallas, TX | 185 | $38K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 401 | Torsemide (Torsemide) | $22.2M | 971,579 |
| 402 | Doxepin Hcl (Doxepin Hcl) | $22.2M | 371,255 |
| 403 | Loteprednol Etabonate (Loteprednol Etabonate) | $22.1M | 85,761 |
| 404 | Mycophenolate Mofetil (Mycophenolate Mofetil) | $22.0M | 152,937 |
| 405 | Tolterodine Tartrate (Tolterodine Tartrate Er) | $21.8M | 178,340 |
| 406 | Chlorthalidone (Chlorthalidone) | $21.8M | 966,780 |
| 407 | Ondansetron (Ondansetron Odt) | $21.5M | 1,261,950 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology